Overxon T 250mg/31.25mg Injection
Marketer
Medivaxia Pharma
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Overxon T 250mg/31.25mg Injection
Combiflox 250mg/31.25mg injection is a dual-action antibiotic, indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, halting infection spread. Administration must be solely under a doctor's guidance; strict adherence to the prescribed schedule is vital. Complete the entire treatment course, regardless of symptom improvement; premature cessation may reduce efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical consultation. Seek urgent medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or vertigo. Ample rest, nutritious food, and hydration contribute to faster recovery. Your doctor may order blood tests and imaging to monitor treatment response.
Uses of Overxon T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Overxon T 250mg/31.25mg Injection:
Administering this medication will be done by your physician or their associate; self-medication is strictly prohibited.
Common Side effects of Overxon T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Overxon T 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
How Overxon T 250mg/31.25mg Injection works:
Overxon T Injection, containing 250mg Ceftriaxone and 31.25mg Tazobactam, employs a dual-action mechanism. Ceftriaxone, an antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. The beta-lactamase inhibitor, Tazobactam, counteracts bacterial resistance, thus potentiating Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Overxon T 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Overxon T (250mg/31.25mg) is typically deemed safe for use during gestation. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; however, data from human trials are scarce.
Breast feedingCAUTION
The administration of Overxon T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Overxon T 250mg/31.25mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Overxon T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Overxon T 250mg/31.25mg requires careful administration in individuals with significant hepatic impairment, potentially necessitating dosage modification. Medical advice is essential. Altering the dosage of Overxon T 250mg/31.25mg Injection is generally not advised for patients experiencing mild to moderate liver dysfunction.
What if you forget to take Overxon T 250mg/31.25mg Injection :
Omit doses of Overxon T 250mg/31.25mg Injection only after physician consultation.
Facts to Know About Overxon T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently